Literature DB >> 27033291

Hepatosplenic T-cell lymphoma in a young immunocompetent man.

Maja Petrova1, Manuel Mendes Gomes1, Jose Pedro Nascimento Carda2, José Pereira de Moura1.   

Abstract

Hepatosplenic T-cell lymphoma (HSTCL) is a rare, aggressive type of peripheral T-cell lymphoma that is characterised by extranodal disease, with infiltration and proliferation of malignant T-cells within the liver, spleen and bone marrow. The authors report the case of a young immunocompetent man, who was admitted to the hospital with a history of prolonged, unexplained fever, fatigue and weight loss. Initial blood work showed mild pancytopaenia and imaging studies revealed hepatosplenomegaly. The diagnosis was challenging, initially mimicking infectious disease, and it required an extensive investigation that ultimately revealed the characteristic clinical, histopathological and cytogenetic features of HSTCL. The clinical course was aggressive, and despite multiagent chemotherapy, the patient died 4 months after the diagnosis. This case highlights the difficulty of diagnosing HSTCL and the importance of considering it in a differential diagnosis of hepatosplenomegaly in young men who present with constitutional symptoms and no lymphadenopathy. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27033291      PMCID: PMC4840752          DOI: 10.1136/bcr-2016-214414

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  36 in total

1.  Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.

Authors:  Ann Corken Mackey; Lanh Green; Li-Ching Liang; Patricia Dinndorf; Mark Avigan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-02       Impact factor: 2.839

2.  Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma.

Authors:  Takaaki Konuma; Jun Ooi; Satoshi Takahashi; Akira Tomonari; Nobuhiro Tsukada; Takeshi Kobayashi; Aki Sato; Arinobu Tojo; Shigetaka Asano
Journal:  Leuk Lymphoma       Date:  2007-03

3.  Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression.

Authors:  Iwona Wlodarska; Nadine Martin-Garcia; Ruth Achten; Chris De Wolf-Peeters; Patrick Pauwels; Micheline Tulliez; Antoine de Mascarel; Josette Brière; Martine Patey; Anne Hagemeijer; Philippe Gaulard
Journal:  Genes Chromosomes Cancer       Date:  2002-03       Impact factor: 5.006

4.  CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma.

Authors:  Ohad Benjamini; Preetesh Jain; Sergej N Konoplev; Cheng Cameron Yin; Lynne Abruzzo; Andrew C Wotherspoon; Claire Dearden; Elizabeth J Shpall; Zeev Estrov; Michael J Keating
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-22

5.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

6.  Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome.

Authors:  A Nosari; P L Oreste; A Biondi; M C Costantini; L Santoleri; L Intropido; G Muti; E Pungolino; L Gargantini; E Morra
Journal:  Am J Hematol       Date:  1999-01       Impact factor: 10.047

7.  Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen.

Authors:  C W Ross; B Schnitzer; S Sheldon; D K Braun; C A Hanson
Journal:  Am J Clin Pathol       Date:  1994-09       Impact factor: 2.493

8.  Hepatosplenic T-cell lymphoma: a rare cause of hepatosplenomegaly.

Authors:  Ana Cristina Lladó; Ana Luisa Tomé; Maria Henrique; Pedro Farinha
Journal:  BMJ Case Rep       Date:  2014-07-10

9.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

Review 10.  Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.

Authors:  Karim Belhadj; Felix Reyes; Jean-Pierre Farcet; Herve Tilly; Christian Bastard; Regis Angonin; Eric Deconinck; Frederic Charlotte; Veronique Leblond; Eric Labouyrie; Pierre Lederlin; Jean-Francois Emile; Beatrice Delmas-Marsalet; Bertrand Arnulf; Elie-Serge Zafrani; Philippe Gaulard
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.